In addition, expression of ALDH1A3 was positively associated with grade in ER-positive tumors, as well as positively correlated with tumor staging, rendering ALDH1A3 a candidate biomarker for metastasis in invasive breast cancers. Here, ALDH1A3 is linked to invasive breast carcinoma.